Medicare Enrolled
Dr. Nagaraja Patil
Internal Medicine · Delmar, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patil?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patil
Dr. Nagaraja Patil is an internal medicine specialist in Delmar, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patil performed 870 Medicare services across 695 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patil received a total of $18,958 from 52 pharmaceutical and/or device companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patil is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 35% volume in NY
$18,958 industry payments
Medicare Practice Summary
Medicare Utilization ↗870
Medicare services
Top 35% in NY for internal medicine
695
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~46 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $51 | $141 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
103 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
79 | $8 | $24 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
77 | $10 | $32 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
67 | $13 | $40 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
44 | $7 | $55 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
33 | $16 | $48 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
32 | $2 | $12 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
32 | $30 | $55 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
30 | $72 | $115 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
27 | $10 | $30 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
27 | $124 | $175 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
21 | $19 | $51 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
20 | $8 | $25 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
19 | $158 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $72 | $210 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
16 | $9 | $26 |
| Fecal immunochemical test (FIT), 1-3 simultaneous A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer. |
12 | $18 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,958
Total received (2018-2024)
Avg $2,708/year across 7 years
Top 5% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
545
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,958 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,529
2023
$4,117
2022
$2,279
2021
$2,014
2020
$1,209
2019
$3,073
2018
$2,737
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$847
GlaxoSmithKline, LLC.
$450
ABBVIE INC.
$371
Amgen Inc.
$239
PFIZER INC.
$209
Boehringer Ingelheim Pharmaceuticals, Inc.
$185
Novo Nordisk Inc
$138
Lilly USA, LLC
$136
Janssen Pharmaceuticals, Inc
$132
Edwards Lifesciences Corporation
$128
Astellas Pharma US Inc
$103
Exact Sciences Corporation
$87
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$82
Abbott Laboratories
$82
Sumitomo Pharma America, Inc.
$71
SANOFI-AVENTIS U.S. LLC
$68
Boston Scientific Corporation
$37
Merck Sharp & Dohme LLC
$34
E.R. Squibb & Sons, L.L.C.
$33
Bayer Healthcare Pharmaceuticals Inc.
$33
Dynavax Technologies Corporation
$17
Phathom Pharmaceuticals, Inc.
$16
Daiichi Sankyo Inc.
$16
Janssen Scientific Affairs, LLC
$14
Top 3 companies account for 47.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,698
Amgen Inc.
$2,771
GlaxoSmithKline, LLC.
$1,445
ABBVIE INC.
$1,043
Janssen Pharmaceuticals, Inc
$992
PFIZER INC.
$862
Lilly USA, LLC
$813
Novo Nordisk Inc
$690
Biohaven Pharmaceuticals, Inc.
$654
Boehringer Ingelheim Pharmaceuticals, Inc.
$548
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$359
Grifols USA, LLC
$353
Astellas Pharma US Inc
$336
Amarin Pharma Inc.
$314
Abbott Laboratories
$313
Teva Pharmaceuticals USA, Inc.
$286
Bayer Healthcare Pharmaceuticals Inc.
$281
Sumitomo Pharma America, Inc.
$274
SANOFI-AVENTIS U.S. LLC
$196
Sunovion Pharmaceuticals Inc.
$171
Biohaven Pharmaceutical Holding Company Ltd.
$168
Exact Sciences Corporation
$165
Allergan Inc.
$159
Gilead Sciences, Inc.
$144
Edwards Lifesciences Corporation
$128
Dexcom, Inc.
$125
Alnylam Pharmaceuticals Inc.
$125
AbbVie Inc.
$125
Esperion Therapeutics, Inc.
$122
AbbVie, Inc.
$122
Novartis Pharmaceuticals Corporation
$121
Kowa Pharmaceuticals America, Inc.
$118
E.R. Squibb & Sons, L.L.C.
$117
Allergan, Inc.
$115
Renalytix AI, Inc.
$105
Bayer HealthCare Pharmaceuticals Inc.
$103
SANOFI PASTEUR INC.
$60
Takeda Pharmaceuticals U.S.A., Inc.
$54
Merck Sharp & Dohme LLC
$54
Merck Sharp & Dohme Corporation
$48
Regeneron Healthcare Solutions, Inc.
$48
Ironwood Pharmaceuticals, Inc
$42
Boston Scientific Corporation
$37
Genentech USA, Inc.
$23
IDORSIA PHARMACEUTICALS US INC
$23
Synergy Pharmaceuticals Inc
$20
Dynavax Technologies Corporation
$17
Phathom Pharmaceuticals, Inc.
$16
Daiichi Sankyo Inc.
$16
Janssen Scientific Affairs, LLC
$14
Avanir Pharmaceuticals, Inc.
$14
IRONWOOD PHARMACEUTICALS, INC
$14
Top 3 companies account for 41.7% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APOLLO ESG System · AREXVY · Aimovig · BASAGLAR · BREO · BREZTRI · BYDUREON · CAMZYOS · CHANTIX · COLOGUARD · COMIRNATY · CREON · Cologuard Collection Kit · DEXCOM G7 GSS (161) · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GEMTESA · GIVLAARI · Gamunex-C · Heplisav-B · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · LINZESS · LONHALA MAGNAIR · LYBREL · LYRICA · Linzess · Livalo · MENACTRA · MOUNJARO · MYRBETRIQ · Motegrity · Myrbetriq · NEXLIZET · NUEDEXTA · NURTEC ODT · OFEV · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tresiba · Trintellix · Trulance · Truvada · UBRELVY · Utibron · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xembify · Xofluza · ZAVZPRET · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for internal medicine in NY.
Geographic Context
Internal medicine physicians within 10 mi
360
Per 100K population
114.2
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patil is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 5% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patil experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Patil performed 214 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patil receive payments from pharmaceutical companies?
Yes. Dr. Patil received a total of $18,958 from 52 companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patil's costs compare to other internal medicine physicians in Delmar?
Dr. Patil's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Delmar
Browse internal medicine physicians in Delmar ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology